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The introduction of dissolution dynamic nuclear polarization (d-DNP) technology has
enabled a new paradigm for renal imaging investigations. It allows standard magnetic
resonance imaging complementary renal metabolic and functional fingerprints within
seconds without the use of ionizing radiation. Increasing evidence supports its utility
in preclinical research in which the real-time interrogation of metabolic turnover can aid
the physiological and pathophysiological metabolic and functional effects in ex vivo and
in vivomodels. The method has already been translated to humans, although the clinical
value of this technology is unknown. In this paper, I review the potential benefits and
pitfalls associated with dissolution dynamic nuclear polarization in preclinical research
and its translation to renal patients.
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RENAL MAGNETIC RESONANCE IMAGING
Magnetic resonance imaging (MRI) is a harmless, non-ionizing imaging modality that provides
excellent soft tissue contrast. Although this technique has been used successfully in several
applications, its full potential is seldom utilized in vivo because of its limited sensitivity. This low
sensitivity increases the acquisition times beyond acceptable time scales for detecting metabolically
active molecules and substrates in low concentrations. To date, renal MRI is used primarily for
morphological examinations in clinical practice. However, for renal functional imaging, several
potentially important alternatives exist, which can provide information on renal physiological
status in terms of fibrosis, oxygenation, and glomerular filtration. These methods have yet to be
translated to clinical practice (Prasad, 2006; Notohamiprodjo et al., 2010). Preclinical and clinical
studies have indicated that these methods hold promise for improving the management and
outcome of patients with renal diseases (Prasad, 2006; Notohamiprodjo et al., 2010).
The complex pathophysiology of renal disease is closely associated with metabolic alterations
that contribute to the disease or are caused as a result of disease progression. Despite tremendous
achievements in understanding the basic mechanism of renal disease, scientists still have poor
insight into the metabolic link between the development and treatment of renal disease. This is
partly because the methods employed to investigate these mechanisms are often destructive ex vivo
methods or in vivo radiolabeled tracer techniques.
Advances in hyperpolarization technology have opened up new avenues for increasing
the sensitivity of diagnostic imaging in humans using both spin exchange optical pumping
(SEOP) and dissolution dynamic nuclear polarization (d-DNP) hyperpolarization. SEOP enables
hyperpolarization of noble gases such as Xenon-129 and Helium-3, while d-DNP enables
Abbreviations: d-DNP, dissolution dynamic nuclear polarization; MRI, magnetic resonance imaging.
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hyperpolarization of carbon-13 in solution (Ardenkjaer-Larsen
et al., 2003). This review focuses on d-DNP for renal imaging
applications.
DISSOLUTION DYNAMIC NUCLEAR
POLARIZATION
Dissolution dynamic nuclear polarization (d-DNP) is a method
that extends the already vast applicability of MRI to provide
real time in situ cellular metabolic information (Ardenkjaer-
Larsen et al., 2003, 2011). The method relies on the generation
of a transient artificial high signal 10,000-fold greater than the
thermal signal at room temperature at clinical MR magnetic
field strengths. This is achieved by placing the sample in a high
magnetic field (typically 3–5 T) at low temperature (typically
1.3–0.8 K), and irradiating it with microwaves to transfer energy
from electron spins to nuclear spins (typically carbon-13),
creating the hyperpolarized sample. The hyperpolarized sample
is then rapidly dissolved to obtain a liquid solution retaining the
transient hyperpolarized signal (Figure 1).
d-DNP MRI relies on an intravenous bolus injection
of carbon-13 (13C)-enriched biomarkers. Thus, high renal
perfusion, metabolic activity, and altered metabolic and
functional status in renal diseases makes this technology
useful for renal investigations (Johansson et al., 2004; Golman
and Petersson, 2006; Leupold et al., 2009). Hyperpolarized
biomarkers enable direct quantification of tracer movement,
as visible on positron emission tomography (PET). Similar
to PET, the hyperpolarized tracer, and not modulation of the
surrounding tissue, is the origin of the signal, as seen on standard
contrast MRI. This allows for background-free images with high
temporal resolution without the use of harmful radiation. The
hyperpolarized signal is typically only observable within 1–2min
after dissolution, similar to the fast decaying PET tracers. The
chemical structure dictates the signal decay rate and thus the
usability of a given molecule, which leads to only small molecules
being candidates for d-DNP imaging in vivo. The use of very
small molecules ensures that bio-probes such as pyruvate, urea,
and fumarate are typically freely filtered by the glomerulus and
reabsorbed in the proximal tubule.
Compared to existing diagnostic tools, hyperpolarized MRI
has a clear advantage in that it detects the metabolic conversion
of 13C-labeled endogenous biomarkers into metabolic derivatives
within the cells in vivo. Thus, it detects physiological and
pathophysiological changes without the need for invasive
biopsies and allows characterization of the entire parenchyma
over time. This factor potentially enables separate assessment
of individual kidneys, the cortex, and medulla, functional
heterogeneity, and focal deficits.
Renal d-DNP MR has received increased attention because
it illustrates the dynamic renal status in normal and diseased
kidneys in a harmless manner (Leupold et al., 2009; Clatworthy
et al., 2012; Laustsen et al., 2013, 2014a,b; Reed et al., 2014).
For patients at risk of developing kidney disease, progressive
knowledge of in vivo renal substrate selection and functional
alterations may help to clarify the mechanisms that cause the
kidney to fail.
The potential of d-DNP MR for metabolic and functional
investigations of the kidneys was recognized early on by Golman
et al. using hyperpolarized renal renograms and perfusion
assessment (Golman et al., 2001; Johansson et al., 2004; Golman
and Petersson, 2006); more importantly, they showed that
hyperpolarized [1-13C]pyruvate could be used for real-time
metabolic imaging in vivo. The localization and metabolic rate
of pyruvate conversion may be important for diagnosis and for
monitoring treatment in renal ischemia reperfusion (Leupold
et al., 2009). It can thus serve as a marker of early renal
dysfunction to guide therapeutic interventions (Laustsen et al.,
2013, 2014b, 2015; Keshari et al., 2015), and highlight potential
targets of therapy so as to prevent progression toward chronic
kidney disease. An increasing amount of evidence supports
the claim of [1-13C] pyruvate as a renal biomarker in diabetic
nephropathy and in ischemia/reperfusion injury.
Although no alterations in renal pyruvate metabolism were
detected in mice with folic acid-induced acute kidney injury,
early tubular necrosis can be detected using fumarate-to-malate
conversion. Fumarate does not readily enter healthy cells,
and therefore, its conversion is observed only when the cell
membrane is permeable. Hence, only early tubular necrosis is
detectable via a positive malate signal (Clatworthy et al., 2012).
In addition to a severely deranged pyruvate metabolism profile
in the early diabetic nephropathic kidney, Keshari et al. (2015)
recently showed increased oxidative stress in diabetic mouse
kidneys by using the novel redox sensor, hyperpolarized [1-13C]
dehydroascorbate. The Keshari study interestingly highlighted
the potential of interrogating oxidative stress modulations, which
showed that angiotensin II treatment reversed the renal redox
status in the diabetic kidney. A particularly interesting alternative
bioprobe for renal investigations—13C-urea—is sensitive to
the intra-renal osmolality gradient—a hallmark of tubular
function. Measuring the intrarenal distribution and perfusion
of urea has been demonstrated to detect alterations in the
distribution between hydration and diuresis (von Morze et al.,
2012). Improved relaxation (decay rate) properties are easily
incorporated by utilizing [13C,15N] urea as the bioprobe. This
avoids the fast relaxation of quadrupolar nitrogen 14 (14N), which
reduces the lifetime of the hyperpolarized sample (Reed et al.,
2014). Hyperpolarized urea may ultimately reveal pathological
changes in the diseased kidney. Recent novel methods that utilize
the relaxation contrast mechanisms of urea are able to identify
increased oxygen consumption in the early diabetic kidney and
during diuresis and antidiuresis with high resolution (Reed et al.,
2015; Laustsen et al., 2016). Urea shows a major potential for
clinical translation as a single metabolite bioprobe, and provides
simple, intuitive, and quantifiable information on the renal status.
These studies together highlight the potential of a conceptual
new framework for future research and drug discovery for renal
diseases.
POTENTIAL AND PITFALLS
Growing evidence supports hyperpolarized MRI as an excellent
research tool in specialized centers; however, several potential
pitfalls exist for its translation into widespread use and clinical
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FIGURE 1 | Dissolution dynamic nuclear polarization magnetic resonance imaging—a “one-stop-shop” methodology. The biomarker is hyperpolarized
and transferred by intravenous injection to the patient inside the clinical scanner. This procedure increases the sensitivity of the measurements by more than 20,000
times, and enables the direct interrogation of renal uptake and metabolic turnover. Standard clinical magnetic resonance imaging (MRI) capabilities are simultaneously
available and provide a very versatile and sensitive diagnostic modality that is free of ionizing radiation and thereby ensures patient safety. DNP, dissolution dynamic
nuclear polarization.
practice. Most noteworthy are the use of apparent rate constants
rather than the “true” rate constants, which would require
significant invasive information on the cellular distribution of
enzymes, cosubstrates, pH, temperature, and the pool sizes of
the substrates for the reactions. This limitation can be partly
overcome by introducing an intervention in the examination,
similar to the furosemide challenge in blood oxygenation level-
dependent (BOLD) MRI, which promotes a change in oxygen
utilization because the required energy need is halted; however,
a quantifiable measure would significantly increase the impact
of the methods. The acquisition and following reconstruction
strategies can also significantly impact the quantification of
the experiments by imposing compromises on the available
information. Hyperpolarized MRI inherently spans a five-
dimensional space (i.e., three spatial, one temporal, and one
spectral dimension); thus, the acquisition of the transient
signal (signal decay due to image acquisition and relaxation
decay) is a compromise between signal availability and the
information needed to answer a particular question. Several
advanced methods have thus been developed for obtaining
metabolic and functional information in d-DNP experiments
(Cunningham et al., 2007, 2008; Leupold et al., 2009; Mayer
et al., 2009; Schmidt et al., 2014). However, this factor
limits the reproducibility and comparability of the results. It
is also imperative to align acquisition, reconstruction, and
analysis protocols to increase the impact in research and
in clinical practice, including standardization of supporting
information, such as oxygenation status, heart rate, and
perfusion.
Non-metabolic biomarkers such as urea for renal functional
imaging can be readily quantified via perfusion mapping similar
to positron emission tomography and relaxation mapping. This
allows easier translation and interpretation of the results.
Most renal investigations have been performed in rodent
models, which have unipapillary kidneys, in contrast to the
multipapillary human kidney. Thus, rodent metabolism is highly
elevated in comparison to that of humans. This difference
between the physiology of the rat and human kidneys imposes
limitations on the interpretation and translatability of the
results. A limited number of studies have been performed in
porcine models, which resemble the human physiology and
show good agreement with the findings in rodents, along with
high intra-animal reproducibility (Laustsen et al., 2015). The
limited resolution often utilized in rodent studies imposes
significant challenges in differentiating the cortical signal from
the medullary signal. This limitation is less pronounced in
large animal models; however, improved resolution is still
needed.
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HUMAN TRANSLATION IN RENAL
PATIENTS
A critical point is patient safety. The current clinically ready
d-DNP system relies on closed sterile samples, denoted fluid
paths, and a non-contact quality control system, which ensures
patient safety. The general tolerability of the pyruvate injection
is high, which showed no adverse events in humans in an initial
human study (Nelson et al., 2013). The production utilizes stable
isotopes and requires only increased capacities of the vendors,
which makes the method an already affordable technology. [1-
13C] Pyruvate is the first bioprobe in themarket, but several other
candidates are in the clinical pipeline such as [2-13C]pyruvate,
[1,4-13C2]fumarate,
13C-urea, and [1-13C]lactate.
The initial human study (Nelson et al., 2013) was performed
on cancer patients. However, the biomarkers and procedures
are similar for renal investigations, and thereby reduce the
transfer time between patient groups. Hyperpolarized MRI
shows great potential for generating new and translational
insights, and thereby advances the basic understanding of renal
pathophysiology and improves the basal needs for treating renal
disease, even without clinical translation. To realize the clinical
potential of renal hyperpolarized MRI, it is essential to improve
the general availability and reproducibility of the method, to
generate strong evidence of its clinical utility by performing
multicenter trials, and to demonstrate the warranted evidence
by comparing it to gold standard methods in patients. An
especially critical point in the translation of the method is the
standardization of the patient with respect to hydration and
metabolic status, as illustrated by the preclinical studies. This is
critical to ensure reproducibility and to maximize the sensitivity
to both disease and interventions.
Although d-DNP has a few but significant pitfalls, it has great
potential as a medical imaging modality. Dissolution-DNP can
potentially change the medical imaging paradigm by allowing
a harmless, so-called “one-stop-shop” imaging methodology. In
this paper, I reviewed the advantages and the pitfalls associated
with dissolution dynamic nuclear polarization in preclinical
research and its translation to renal patients. The findings of
this review suggest that this technology may generate new and
translational insights, advance the basic understanding of renal
pathophysiology, and improve the treatment of renal disease,
even without clinical translation.
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